Study Shows Advantages of Degarelix
MILAN—The investigational agent degarelix provides more rapid and profound testosterone suppression than conventional androgen deprivation therapy in men with advanced prostate cancer, researchers reported. Degarelix is a new synthetic peptide gonadotropin-releasing hormone (GnRH) blocker.